Cerebral embolism and hormone replacement therapy.

about

Cerebral embolism and hormone replacement therapy.

Item

http://www.wikidata.org/entity/Q43651101

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Cerebral embolism and hormone replacement therapy.

@en

Cerebral embolism and hormone replacement therapy.

@nl

type

Item

label

Cerebral embolism and hormone replacement therapy.

@en

Cerebral embolism and hormone replacement therapy.

@nl

prefLabel

Cerebral embolism and hormone replacement therapy.

@en

Cerebral embolism and hormone replacement therapy.

@nl

P1476

Cerebral embolism and hormone replacement therapy.

@en

P2093

Hashiguchi A

http://www.w3.org/2001/XMLSchema#string

Inoue N

http://www.w3.org/2001/XMLSchema#string

Kihara K

http://www.w3.org/2001/XMLSchema#string

Maehara F

http://www.w3.org/2001/XMLSchema#string

Ushio Y

http://www.w3.org/2001/XMLSchema#string

Yoshioka S

http://www.w3.org/2001/XMLSchema#string

P2860

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

17beta-estradiol reduces stroke injury in estrogen-deficient female animals.

The adverse effects of hormone replacement therapy.

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.

Thromboembolic complications associated with reproductive endocrinologic procedures.

The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of literature.

Hormonal steroid contraceptives. 3. Adverse reactions.

Cerebral emboli of paradoxical origin.

Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.

Adjuvant antiestrogen treatment with tamoxifen in postmenopausal women with breast cancer: a longitudinal study of blood coagulation and fibrinolysis.

P304

181-186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2710.2001.00343.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2001-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11422601

http://www.w3.org/2001/XMLSchema#string